Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers report details of new studies and findings in the area of breast cancer
February 2nd, 2006
Breast cancer data are the focus of recent research from South Korea, Italy and United Kingdom. Study 1: Early response to neoadjuvant infusional 5-fluorouracil, adriamycin and cyclophosphamide (IFAC) predicted a favorable prognosis in breast cancer. "The aim of this study was to evaluate the efficacy and safety of neoadjuvant chemotherapy with iFAC in locally advanced breast cancer (LABC). Eighty-two LABC patients were treated with neoadjuvant iFAC chemotherapy including infusional 5-FU (1000 mg/m2, continuous intravenous infusion, days 1-3), adriamycin (40 mg/m2, intravenous bolus, day 1) and cyclophosphamide (600...
Source: Women's Health Weekly (2006-02-02)
|
